Interventional, Open-Label, Single Cohort, Canadian Study to Describe the Relationship Between Cognitive Symptoms and Work Productivity in Working Adults Treated With Vortioxetine for Major Depressive Disorder (MDD)
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms AtWoRC
- Sponsors Lundbeck Canada
- 22 Jan 2018 Status changed from active, no longer recruiting to completed.
- 24 May 2017 Results of a primary analysis (n=196), presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 09 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Aug 2017.